Intrathecal (IT) traztuzumab (T) for the treatment of leptomeningeal metastases (LM) in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) cancer: A multicenter phase 1/2 study Meeting Abstract
| Authors: | Kumthekar, P.; Gradishar, W.; Lin, N.; Pentsova, E.; Groves, M.; Jeyapalan, S.; Melisko, M.; Grimm, S.; Lassman, A. B.; Raizer, J. |
| Abstract Title: | Intrathecal (IT) traztuzumab (T) for the treatment of leptomeningeal metastases (LM) in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) cancer: A multicenter phase 1/2 study |
| Meeting Title: | 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 20 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2018 Nov 15-18 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | vi58 |
| Language: | English |
| ACCESSION: | WOS:000460646300236 |
| PROVIDER: | wos |
| PMCID: | PMC6216117 |
| DOI: | 10.1093/neuonc/noy148 |
| Notes: | Meeting Abstract: CMET-22 -- Source: Wos |
